NCT06985576View on ClinicalTrials.gov

Long-term Study to Evaluate Safety and Persistence of GF-CART01

Not yet recruitingOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2026

Primary Completion Date

May 31, 2041

Study Completion Date

May 31, 2041

Conditions
DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma (FL)Primary Mediastinal Large B-Cell LymphomaHigh Grade B Cell Lymphoma
Trial Locations (1)

100

National Taiwan University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

GenomeFrontier Therapeutics TW Co., Ltd.

INDUSTRY

NCT06985576 - Long-term Study to Evaluate Safety and Persistence of GF-CART01 | Biotech Hunter | Biotech Hunter